There is one big reason that minerals are extremely important. If certain minerals are deficient in your body then those genes that fight cancer are not activated.
Selenium is one such mineral that is necessary to activate certain genes to help you suppress the formation of cancer cells. Here is what selenium does in your body to fight cancer and improve your immune system.
China’s fastest-growing automaker, GAC Motor, has released two new SUVs onto the market, the 5-seat GS7 and the entry SUV GS3 in watertown Wuzhen, Zhejiang Province, China where tradition embraces innovation. These two next-generation SUVs, which have inherited the excellent genes of the GAC Motor family, are poised to bolster the company’s already astounding growth and drive its plans for global expansion.
GAC Motor chose Wuzhen as the place to begin its redefinition of SUVs for young consumers because of the water town’s rich history, its status as a hotbed for high-tech and innovation, and because of its youthful, fashionable and forward-thinking vibes, which is in line with the targeted young consumers of the two new models. Since 2014, Wuzhen has been the home for the World Internet Conference, which attracts prominent internet figures from 120 countries.
To view the multimedia release go to:
https://www.multivu.com/players/English/8166551-gac-motor-gs7-gs3-launch/
23andMe, working in collaboration with the Milken Institute and Lundbeck, today announced that they have commenced enrollment for a first-of-its kind genetic study designed to gain understanding of the underlying biology of major depressive and bipolar disorders. This study will combine cognitive assessments with genetic data and survey responses to assess how genes influence brain processes – such as attention, decision-making and visual perception – in individuals who live with these serious mental health conditions.
“We know genetics play a role in the development of depression and bipolar, however there is a long pathway from our genes to the manifestation of complex diseases like these,” said Emily Drabant Conley, PhD., Vice President of Business Development at 23andMe. “We need to look at these conditions in a more comprehensive way to advance our understanding. By studying cognitive function alongside genetics and other environmental variables on a massive scale, we hope to take a significant step forward in the study of depression and bipolar.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8150951-23andme-genetic-study-depression-bipolar-disorders/
El pasado domingo 5 de junio, El Dasa, protagonista de la exitosa serie “El Vato”, ofreció un concierto gratuito en Universal CityWalk™ presentado por NBC UNIVERSO donde fans de todas las edades acudieron a ver a su ídolo. El popular locutor de la Súper Estrella 107.1 FM, Eddie “Piolín” Sotelo, estuvo a cargo de la conducción y de presentar al talentoso y carismático cantante de Hermosillo, Sonora. Para descargar imágenes de los mejores momentos del concierto de El Dasa haga clic aquí y para ver el video, ingrese aquí.
El Dasa arrancó el concierto cantando “Perdí el Sombrero”, el tema principal de “El Vato”, la serie original de NBC UNIVERSO creada para el mercado hispano en Estados Unidos. Luego le siguió con “Alegre y Enamorado”, un tema que rinde tributo a todos los estados de México y donde la emoción de los asistentes se sintió cada vez que se mencionaba su estado natal. Pero el ambiente se prendió cuando el Dasa empezó a bailar con sus movimientos sensuales de cadera al cantar “Mentirosa”. La canción que desató gritos efusivos fue cuando El Dasa dedicó a todas las damitas “Por ser Bonita”. Aparte de cantar sus éxitos y otras clásicas canciones de banda, los asistentes tuvieron la primicia de escuchar “Ya me vi”, el primer sencillo de su nuevo material discográfico que saldrá a la venta este verano.
To view the multimedia release go to:
http://www.multivu.com/players/Spanish/7609253-nbc-universo-el-vato-citywalk/
The most detailed analysis yet of the role germline mutations in genes associated with cancer predisposition play in the development of childhood cancer suggests that comprehensive genomic screening may be warranted on all pediatric cancer patients, not just those with a family history of cancer. The study from the St. Jude Children’s Research Hospital – Washington University Pediatric Cancer Genome Project appears in the November 19 edition of the New England Journal of Medicine.
Ultimately, researchers anticipate that systematic monitoring of patients and family members who have germline mutations in cancer predisposition genes will allow the detection of cancers at their earliest and most curable stage, thereby improving the outcomes for these children and family members.
To view the multimedia release go to:
http://www.multivu.com/players/English/7692851-st-jude-hospital-genome-project/
Professor Lionel Tarassenko, CBE, Head of Engineering at the University of Oxford and Fellow of the Royal Academy of Engineering and the Academy of Medical Sciences, has joined a panel of internationally recognised experts for the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
As the worlds of science and technology come together, the 2015 Astellas Innovation Debate, organised and funded by Astellas, will discuss recent breakthroughs in genetic medicine and smart technology, and what they mean for our health.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7432051-lionel-tarassenko-astellas-debate/
Advanced technology has the power to transform healthcare, a world leader in the field of genomicsDr Leroy Hood, has said ahead of the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7430051-dr-leroy-hood-astellas-debate/
Personalised Medicine is the future of cancer treatment, but it presents major challenges for doctors and health services, the President of the European Society of Medical Oncology has said. Professor Rolf Stahel was speaking ahead of the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7430351-professor-rolf-stahel-astellas-debate/
Barrister, peer and Vice-President of the Patients Association Baroness Helena Kennedy has joined a panel of internationally recognised experts for the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
Organised and funded by Astellas, a progressive pharmaceutical company that explores the frontiers of scientific discovery to translate new knowledge into innovative, reliable medicines, the Astellas Innovation Debates are a series of annual events that bring together some of the world’s most progressive thinkers to discuss the role of innovation in solving some of the greatest challenges of our time.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7424051-helena-kennedy-astellas-debate/
George Freeman MP, the Minister for Life Sciences, will give the keynote address at the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
Organised and funded by Astellas, a progressive pharmaceutical company that explores the frontiers of scientific discovery to translate new knowledge into innovative, reliable medicines, the Astellas Innovation Debates are a series of annual events that bring together some of the world’s most progressive thinkers to discuss the role of innovation in solving some of the greatest challenges of our time.
George Freeman’s keynote address will outline the Government’s aim to develop, assess and adopt new drugs, devices and diagnostics as we move towards 21st century, personalised healthcare.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7423951-george-freeman-astellas-debate/
BloodCenter of Wisconsin’s Diagnostic Laboratories today announced the availability of a comprehensive cancer mutation HemeOnc Panel using next generation sequencing (NGS) technology. The NGS panel developed by BloodCenter of Wisconsin is designed to detect variants in 30 genes that are either prognostic or diagnostic for 10 different myeloid hematologic malignancies.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7363151-bloodcenter-of-wisconsin-launches-next-generation-sequencing-hemeonc-panel/
El satélite DEIMOS-2, el primero español de muy alta resolución puesto en órbita el pasado 19 de junio, ha comenzado a captar sus primeras imágenes tan solo 12 horas de entrar en operación.
DEIMOS-2, lanzado desde la base de lanzamiento de Yasny (Rusia), ha sido desarrollado en un tiempo récord de tres años por Elecnor Deimos. Para la integración y posterior control de la misión DEIMOS-2, la compañía ha creado un innovador Centro de Integración y Operaciones de Satélites en Puertollano (España), completando así su presencia en toda la cadena de valor de las misiones espaciales.
Para ver el Multimedia News Release, vaya a http://www.multivu.com/mnr/71400573-elecnor-deimos-2-satellite-images
